Loading…

Hepatic Resection for Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease

Objective:. To systematically review and compare the overall (OS) and disease-free (DFS) survival after hepatic resections for hepatocellular carcinoma (HCC) of patients with nonalcoholic fatty liver disease (NAFLD) versus other risk factors. Background:. Different clinical and tumor characteristics...

Full description

Saved in:
Bibliographic Details
Published in:Annals of surgery open 2021-06, Vol.2 (2), p.e065
Main Authors: Michele Molinari, MD, MSc, Christof Kaltenmeier, MD, Patrick-Bou Samra, MD, Hao Liu, MD, PhD, Charles Wessel, MLS, Mary Lou Klem, MLS, Stalin Dharmayan, MD, Bishoy Emmanuel, MD, Hasan Al Harakeh, MD, Samer Tohme, MD, David Geller, MD, Amit Tevar, MD, Christopher B. Hughes, MD, Abhinav Humar, MD, Ramon Bataller, MD, PhD, Jaideep Behari, MD
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective:. To systematically review and compare the overall (OS) and disease-free (DFS) survival after hepatic resections for hepatocellular carcinoma (HCC) of patients with nonalcoholic fatty liver disease (NAFLD) versus other risk factors. Background:. Different clinical and tumor characteristics are associated with HCC in the setting of NAFLD in comparison to other risk factors. It is still unclear whether these differences impact patient survival after radical hepatectomies. Methods:. Randomized controlled trials and observational studies published in the English literature between July 1980 and June 2020 were searched using multiple databases. Patients’ baseline characteristics and the hazard ratios (HRs) of the OS and DFS were extracted and meta-analyses were performed. Results:. Fifteen retrospective cohort studies with a total of 7226 patients were included. Among them, 1412 patients (19.5%) had NAFLD and 5814 (80.4%) had other risk factors (eg, viral hepatitis B or C, alcoholic cirrhosis, or cryptogenic cirrhosis). Summary statistics showed that patients with NAFLD had better DFS (HR = 0.81; 95% CI: 0.70–0.94; P = 0.006) and OS (HR = 0.78; 95% CI: 0.67–0.90; P = 0.001) than the control group. Subgroups analyses also indicated that the OS favored NAFLD patients versus patients with viral hepatitis B or C (HR = 0.80; 95% CI: 0.67–0.96; P = 0.017) or alcoholic and cryptogenic cirrhosis (HR = 0.68; 95% CI: 0.47–1.0; P = 0.05). Conclusion:. After hepatic resections for HCC, NAFLD patients have better DFS and OS than patients with other risk factors. Subgroup analysis and meta-regression suggested that the survival advantage of NAFLD patients was more pronounced in studies published after 2015 and from Asian centers.
ISSN:2691-3593
DOI:10.1097/AS9.0000000000000065